Breaking News

Quintiles, TMAC Sign Commercial Capabilities Pact

By Kristin Brooks | January 7, 2014

Expands integrated commercialization programs for U.S. customers

Quintiles and The Medical Affairs Company (TMAC) have entered a collaboration expanding each company’s medical affairs-related offerings for customers in the U.S. Quintiles will add TMAC’s medical science liaison (MSL) capabilities to its field-based medical solutions, with the goal of providing additional expertise to engage and encourage increased knowledge of research, products and devices. The collaboration also allows TMAC to leverage Quintiles’ clinical educators to facilitate ongoing education of healthcare professionals, patients and caregivers.
“Today, more than ever before, biopharma companies looking to commercialize products in the U.S. are focused on demonstrating the value and benefits of their products to an increasingly diverse range of stakeholders,” said Daryl Gaugler, senior vice president, Commercial Solutions at Quintiles. “As this stakeholder landscape and its requirements continue to evolve, we are delighted to be working alongside a company like TMAC to offer the full spectrum of commercialization services, with an integrated approach to sales, medical science liaison, clinical education and market entry.”
“Requirements for medical affairs activities are expanding across the product life cycle,” said Evan Demestihas, M.D., chief executive officer, TMAC. “Working with companies like TMAC and Quintiles provides customers with benefits in terms of strategic oversight, speedy deployment and operational flexibility, while maintaining the discipline-specific and therapy area expertise that are essential to medical affairs teams. Through this collaboration, we believe Quintiles and TMAC will offer customers turn-key field commercialization capabilities that are unmatched in our industry.”

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Cryogenic Cold Chain Risk Mitigation

    Cryogenic Cold Chain Risk Mitigation

    Kristin Brooks, Contract Pharma||November 13, 2015
    Mark Sawicki of Cryoport explains the requirements, challenges, and regulatory aspects around cryogenic logistics

  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.